Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria~* Participants who qualified and entered the core study.~* Participants who participated in the core study, completed Period 1 and were re-randomized in Period 2 and continued for at least 3 days in Period 2.~Exclusion criteria~* Participants who did not complete Period 1 of the core study.~* Participants who were re-randomized in Period 2 of core study but did not continue for =\> 3 days in Period 2 of the core study.~* Participants who experienced any adverse events considered serious or drug related in the core study.~* Participants excluded from the core study.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- Valsartan Open Label (Type: EXPERIMENTAL): Extemporaneous oral suspension prepared from valsartan tablets was administered to participants once daily. The starting dose of valsartan was 1 mg/kg, escalated to 2 mg/kg or 4 mg/kg based on mean sitting systolic blood pressure (MSSBP) control after 2 weeks up to 18 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).